Genetic Testing for Familial Hypertrophic Cardiomyopathy in Newborn Infants: Clinicians' Perspective -- an Ethical Debate
Ryan, Mark P.
Cleland, John G.F.
Oakley, Celia M.
Harper, Peter S.
BMJ (British Medical Journal). 1995 Apr 1; 310(6983): 856-859.
Identification of genes for hypertrophic cardiomyopathy has made preclinical diagnosis possible in families with a mutation. As yet, however, no treatment prevents the development of myocardial hypertrophy, and medical intervention has not been shown to improve prognosis. A team from Hammersmith Hospital carrying out research into genetic causes of the disease report that they were asked by a couple to screen their daughter at birth. The couple also give their view of screening. We asked two medical geneticists, a cardiologist, and a paediatrician with an interest in ethics to comment on the implications.
Behavior Control; Case Studies; Counseling; Consent; Diagnosis; Disease; Discrimination; Employment; Ethical Review; Ethics; Ethics Committees; Genes; Genetic Disorders; Genetic Research; Genetic Testing; Genetic Screening; Infants; Insurance; Late-Onset Disorders; Mutation; Newborns; Parental Consent; Prognosis; Psychological Stress; Research; Review; Risks and Benefits; Social Discrimination; Stigmatization; Uncertainty;
Showing items related by title, author, creator and subject.
An Ethical Debate -- Genetic Testing for Familial Hypertrophic Cardiomyopathy in Newborn Infants: Clinicians' Perspective French, Julie; Al-Mahdawi, Sahar; Nihoyannopoulos, Petros; Ryan, Mark P. (1995-04-01)